Skip to main content
Equibles
ARDX logo

ARDX · Ardelyx, Inc. · Metrics

Track ARDX — free

Use ARDX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ARDX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.16 -0.06 (-1.71%)
Russell 2000 member Rebalance outlook locked
Market Cap
$797.40M
Shares
249.19M
Volume · Oct 21 1.03M Avg daily vol (3M) 4.36M

ARDX metrics

89 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$3.21
Market cap
$797.40M

Price action

20 metrics
Price change (1W)
+2.9%
Price change (30D)
-8.3%
Price change (3M)
-36.9%
Price change (6M)
-46.1%
Price change (YTD)
-44.9%
Price change (1Y)
-37.1%
Trailing year
Price change (5Y)
+191.8%
52-week high
$7.99
52-week low
$3.09
Change from 52-week high
-59.8%
Change from 52-week low
+3.9%
Annualized volatility
61.8%
Annualized volatility (3M)
46.4%
Beta
0.8
RSI (14D)
40.2
Price vs SMA 50
-10.1%
Price vs SMA 200
-41.4%
Avg volume (3M)
4.36M
Relative volume
0.9
Average dollar volume
$16.54M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
249.19M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
2.1×
reciprocal yield 47.4%
EV / EBITDA
—
EV / EBIT
—
P / sales
1.8×
reciprocal yield 56.5%
P / book
5.4
reciprocal yield 18.7%
FCF yield
-2.2%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-7.0%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
6.0×
reciprocal yield 16.6%
EV / revenue historical average (5Y)
9.7×
reciprocal yield 10.3%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-11-03
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
—
Operating margin
-7.9%
Trailing 12 months
Net margin
-12.4%
Gross profit (TTM)
—
Operating profit (TTM)
−$35.45M
Net income (TTM)
−$55.70M
Trailing 12 months
Diluted EPS (TTM)
$-0.23
FCF margin
-4.0%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$1.84
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$-0.14
EBITDA per diluted share (TTM)
$-0.13
Net income per diluted share (TTM)
$-0.23
Operating cash flow per diluted share (TTM)
$-0.07
Free cash flow per diluted share (TTM)
$-0.07
Capital expenditures per diluted share (TTM)
$0.00
R&D per diluted share (TTM)
$0.36
Stock compensation per diluted share (TTM)
$0.22
Book value per share
$0.68

Growth

11 metrics
Revenue growth YoY
+23.8%
Year over year
Net income growth YoY
—
Revenue (TTM)
$450.89M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+3.4%
Year over year · more shares
Revenue CAGR (3Y)
+98.4%
Revenue CAGR (5Y)
+121.9%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-37.4%
Return on assets
-9.7%
Debt / equity
1.7
Current ratio
3.3
EBITDA (TTM)
−$32.11M
Free cash flow (TTM)
−$17.92M
Quick ratio
2.3
Interest coverage
-1.6
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$154.63M
Latest balance sheet
Cash & equivalents
$97.19M
Total assets
$575.89M
Total debt
$251.82M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$17.32M
Capital expenditures (TTM)
$599,000
R&D (TTM)
$87.21M
SG&A (TTM)
$373.73M
Stock compensation (TTM)
$54.66M
R&D / revenue
19.3%
Stock compensation / revenue
12.1%

Ownership (13F)

9 metrics
13F filers
252
13F filer change QoQ
+9
Institutional ownership
72.2%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
25.9%
Private-fund adviser ownership
23.5%
Active holders' share change QoQ
+5.3%
Holder tenure
10.1
Price vs estimated holder cost
-10.3%

Ownership (registered funds)

1 metrics
Index-fund ownership
16.5%

Short interest

3 metrics
Short interest
11.1%
Latest settlement · 6.6 days to cover
Days to cover
6.6d
Short-squeeze score
64 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$486,197
Insider-sentiment score
21 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1437402 CUSIP 039697107 13F (30d) 17 filings 17 filers Visit website Investor relations